Intracoronary Stenting and Angiographic Results
Top Cited Papers
- 12 June 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (23) , 2816-2821
- https://doi.org/10.1161/01.cir.103.23.2816
Abstract
Background —Increased thrombogenicity and smooth muscle cell proliferative response induced by the metal struts compromise the advantages of coronary stenting. The objective of this randomized, multicenter study was to assess whether a reduced strut thickness of coronary stents is associated with improved follow-up angiographic and clinical results. Methods and Results —A total of 651 patients with coronary lesions situated in native vessels >2.8 mm in diameter were randomly assigned to receive 1 of 2 commercially available stents of comparable design but different thickness: 326 patients to the thin-strut stent (strut thickness of 50 μm) and 325 patients to the thick-strut stent (strut thickness of 140 μm). The primary end point was the angiographic restenosis (≥50% diameter stenosis at follow-up angiography). Secondary end points were the incidence of reinterventions due to restenosis-induced ischemia and the combined rate of death and myocardial infarctions at 1 year. The incidence of angiographic restenosis was 15.0% in the thin-strut group and 25.8% in the thick-strut group (relative risk, 0.58; 95% CI, 0.39 to 0.87; P =0.003). Clinical restenosis was also significantly reduced, with a reintervention rate of 8.6% among thin-strut patients and 13.8% among thick-strut patients (relative risk, 0.62; 95% CI, 0.39 to 0.99; P =0.03). No difference was observed in the combined 1-year rate of death and myocardial infarction. Conclusions —The use of a thinner-strut device is associated with a significant reduction of angiographic and clinical restenosis after coronary artery stenting. These findings may have relevant implications for the currently most widely used percutaneous coronary intervention.Keywords
This publication has 12 references indexed in Scilit:
- A randomized trial comparing the hand‐mounted JoStent with the premounted Multi‐Link Duet stent in patients with coronary artery diseaseCatheterization and Cardiovascular Interventions, 2001
- Restenosis after coronary placement of various stent typesThe American Journal of Cardiology, 2001
- Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stentingThe American Journal of Cardiology, 2000
- Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 2000
- Influence of stent design on 1-year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patientsCatheterization and Cardiovascular Interventions, 2000
- Influence of Topography on Endothelialization of Stents: Clues for New DesignsJournal of Long-Term Effects of Medical Implants, 2000
- Procedural and late outcomes following MULTI-LINK DUET coronary stent deploymentThe American Journal of Cardiology, 1999
- Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa ReceptorsNew England Journal of Medicine, 1999
- Pathobiologic Responses to Stenting 11Supported in part by grants from the National Institutes of Health (GM/HL49039 and HL03104), the Burroughs Wellcome Fund for Experimental Therapeutics, Durham, North Carolina, and the Whitaker Foundation, Rosslyn, Virginia.The American Journal of Cardiology, 1998
- Intravascular Ultrasound to Discern Device-Specific Effects and Mechanisms of RestenosisThe American Journal of Cardiology, 1996